A Clinical Trial to Compare the Safety, Tolerability, and PK Properties of DA-5216 and DA-5216-R and to Evaluate the Food Effect on DA-5216.

Phase 1 Unknown 88 enrolled Dong-A ST Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

This is a randomized, open-label, single dose, 2-part, cross-over clinical trial to compare the safety, tolerability, and pharmacokinetic properties of DA-5216 and DA-5216-R and to evaluate the food effect on DA-5216 in healthy adult subjects

Timeline

Start: 2022-08-29
Primary completion: 2022-10
Completion: 2022-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	DA-5216	Unknown	—	—
Subject	DA-5216-R	Unknown	—	—

Indications

No indication recorded.